294 related articles for article (PubMed ID: 9365159)
1. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
Vos CB; Cleton-Jansen AM; Berx G; de Leeuw WJ; ter Haar NT; van Roy F; Cornelisse CJ; Peterse JL; van de Vijver MJ
Br J Cancer; 1997; 76(9):1131-3. PubMed ID: 9365159
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction.
Nayar R; Zhuang Z; Merino MJ; Silverberg SG
Hum Pathol; 1997 Mar; 28(3):277-82. PubMed ID: 9042790
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
4. Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas.
Rieger-Christ KM; Pezza JA; Dugan JM; Braasch JW; Hughes KS; Summerhayes IC
Mol Pathol; 2001 Apr; 54(2):91-7. PubMed ID: 11322170
[TBL] [Abstract][Full Text] [Related]
5. Cadherin-catenin complex dissociation in lobular neoplasia of the breast.
Morrogh M; Andrade VP; Giri D; Sakr RA; Paik W; Qin LX; Arroyo CD; Brogi E; Morrow M; King TA
Breast Cancer Res Treat; 2012 Apr; 132(2):641-52. PubMed ID: 22080244
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.
Zou D; Yoon HS; Perez D; Weeks RJ; Guilford P; Humar B
J Pathol; 2009 Jun; 218(2):265-72. PubMed ID: 19294736
[TBL] [Abstract][Full Text] [Related]
7. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?
Bagaria SP; Shamonki J; Kinnaird M; Ray PS; Giuliano AE
Ann Surg Oncol; 2011 Jul; 18(7):1845-51. PubMed ID: 21287281
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast.
Mastracci TL; Tjan S; Bane AL; O'Malley FP; Andrulis IL
Mod Pathol; 2005 Jun; 18(6):741-51. PubMed ID: 15696125
[TBL] [Abstract][Full Text] [Related]
9. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast.
Buerger H; Simon R; Schäfer KL; Diallo R; Littmann R; Poremba C; van Diest PJ; Dockhorn-Dworniczak B; Böcker W
Mol Pathol; 2000 Jun; 53(3):118-21. PubMed ID: 10897329
[TBL] [Abstract][Full Text] [Related]
10. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
Dabbs DJ; Schnitt SJ; Geyer FC; Weigelt B; Baehner FL; Decker T; Eusebi V; Fox SB; Ichihara S; Lakhani SR; Palacios J; Rakha E; Richardson AL; Schmitt FC; Tan PH; Tse GM; Vincent-Salomon A; Ellis IO; Badve S; Reis-Filho JS
Am J Surg Pathol; 2013 Jul; 37(7):e1-11. PubMed ID: 23759937
[TBL] [Abstract][Full Text] [Related]
11. Germline CDH1 mutations in bilateral lobular carcinoma in situ.
Petridis C; Shinomiya I; Kohut K; Gorman P; Caneppele M; Shah V; Troy M; Pinder SE; Hanby A; Tomlinson I; Trembath RC; Roylance R; Simpson MA; Sawyer EJ
Br J Cancer; 2014 Feb; 110(4):1053-7. PubMed ID: 24366306
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of E-cadherin in lobular carcinomas of the breast.
Da Silva L; Parry S; Reid L; Keith P; Waddell N; Kossai M; Clarke C; Lakhani SR; Simpson PT
Am J Surg Pathol; 2008 May; 32(5):773-83. PubMed ID: 18379416
[TBL] [Abstract][Full Text] [Related]
13. Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene.
Rahman N; Stone JG; Coleman G; Gusterson B; Seal S; Marossy A; Lakhani SR; Ward A; Nash A; McKinna A; A'Hern R; Stratton MR; Houlston RS
Br J Cancer; 2000 Feb; 82(3):568-70. PubMed ID: 10682667
[TBL] [Abstract][Full Text] [Related]
14. [Expression of Twist, E-cadherin and N-cadherin in breast carcinoma and their clinical significance].
Ma YH; Wang K; Li L; Lu ZH; Chen J
Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):5-9. PubMed ID: 20388391
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.
Goldstein NS; Kestin LL; Vicini FA
Cancer; 2001 Aug; 92(4):738-47. PubMed ID: 11550142
[TBL] [Abstract][Full Text] [Related]
16. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
Palacios J; Sarrió D; García-Macias MC; Bryant B; Sobel ME; Merino MJ
Mod Pathol; 2003 Jul; 16(7):674-8. PubMed ID: 12861063
[TBL] [Abstract][Full Text] [Related]
17. Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?
Karch I; Schipper E; Christgen H; Kreipe H; Lehmann U; Christgen M
PLoS One; 2013; 8(8):e73062. PubMed ID: 24023670
[TBL] [Abstract][Full Text] [Related]
18. Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships.
Sakr RA; Schizas M; Carniello JV; Ng CK; Piscuoglio S; Giri D; Andrade VP; De Brot M; Lim RS; Towers R; Weigelt B; Reis-Filho JS; King TA
Mol Oncol; 2016 Feb; 10(2):360-70. PubMed ID: 26643573
[TBL] [Abstract][Full Text] [Related]
19. Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer.
Aulmann S; Penzel R; Longerich T; Funke B; Schirmacher P; Sinn HP
Breast Cancer Res Treat; 2008 Feb; 107(3):331-5. PubMed ID: 17380381
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]